Find a Doctor

BP
Areas of Expertise

Brad L. Pohlman

Cleveland Clinic Foundation
Hematology, Oncology, Internal Medicine
Male
Practicing approx. 36 years
Approx. age 62

Bio

Brad Pohlman is an Internal Medicine specialist and a Hematologist in Cleveland, Ohio. He has been an author on 106 peer reviewed articles in the past 15 years. He is licensed to treat patients in OH.

Areas of Expertise

Contact

9500 Euclid Ave
Cleveland, OH 44195, US

Latest Research

Latest Advance
Study
  • Condition: Risk of Relapse in Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplantation (ASCT)
  • Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Treatment Used: Therapeutic Dose Monitoring (TDM) of Busulfan (Bu)Therapeutic Dose Monitoring of Busulfan
  • Number of Patients: 336
  • Published —
This study compared outcomes of patients with non-Hodgkin lymphoma (NHL) undergoing autologous stem cell transplantation (ASCT) with busulfan/cyclophosphamide/etoposide (Bu/Cy/E) using weight-based dosing (WBD) versus those who did so using therapeutic drug monitoring (TDM) of busulfan.
Latest Advance
Study
  • Condition: Diffuse Large B Cell Lymphoma
  • Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Treatment Used: Autologous Hematopoietic Cell Transplant (AHCT)
  • Number of Patients: 371
  • Published —
This study tested the safety and efficacy of using AHCT to treat patients with diffuse large B cell lymphoma.
Latest Advance
Study
  • Condition: Hodgkin Lymphoma
  • Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Treatment Used: BEAM versus BUCYVP16 Conditioning
  • Number of Patients: 233
  • Published —
In this study, researchers compared the effectiveness of BEAM versus BUCYVP16 conditioning before autologous hematopoietic stem cell transplant for the treatment of Hodgkin lymphoma.

Clinical Trials

This doctor has not participated in any recent clinical trials.

All Publications
View All

Publication
Study
  • Journal: Leukemia & lymphoma
  • Published —
Outcomes and factors impacting use of axicabtagene ciloleucel in patients with relapsed or refractory large B-cell lymphoma: results from an intention-to-treat analysis.
Publication
Study
  • Journal: Hematology/oncology and stem cell therapy
  • Published —
Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era.

Contact

9500 Euclid Ave
Cleveland, OH 44195, US

Affiliations

  • Cleveland Clinic
  • Akron General Medical Center
  • Hillcrest Hospital

Credentials

  • Graduate InstitutionIndiana University School Of Medicine
    1985
  • Licenses
    Internal Medicine in OH
  • Board Certifications
    Internal Medicine
    Hematology/oncology

Insurance

Contact them to find out if they accept your insurance plan.